DRD2 is overexpressed in endometrial cancer and confers poor prognosis. DRD2 antagonism by ONC201 elicits efficacy in an endometrial cancer genetic mouse model. Please find the full paper here.
Business Development
© Copyright 2020 Oncoceutics, Inc. All Rights Reserved.